Wiese M - Search Results

1

Synthesis and quantitative structure-activity relationships of selective BCRP inhibitors.

Marighetti F, Steggemann K, Hanl M, Wiese M. Marighetti F, et al. Among authors: wiese m. ChemMedChem. 2013 Jan;8(1):125-35. doi: 10.1002/cmdc.201200377. Epub 2012 Nov 13. ChemMedChem. 2013. PMID: 23150210

2

Interactions of the multidrug resistance modulators tariquidar and elacridar and their analogues with P-glycoprotein.

Pajeva IK, Sterz K, Christlieb M, Steggemann K, Marighetti F, Wiese M. Pajeva IK, et al. Among authors: wiese m. ChemMedChem. 2013 Oct;8(10):1701-13. doi: 10.1002/cmdc.201300233. Epub 2013 Aug 13. ChemMedChem. 2013. PMID: 23943604

3

Scaffold identification of a new class of potent and selective BCRP inhibitors.

Marighetti F, Steggemann K, Karbaum M, Wiese M. Marighetti F, et al. Among authors: wiese m. ChemMedChem. 2015 Apr;10(4):742-51. doi: 10.1002/cmdc.201402498. Epub 2015 Mar 3. ChemMedChem. 2015. PMID: 25735648

4

Specific inhibitors of the breast cancer resistance protein (BCRP).

Pick A, Klinkhammer W, Wiese M. Pick A, et al. Among authors: wiese m. ChemMedChem. 2010 Sep 3;5(9):1498-505. doi: 10.1002/cmdc.201000216. ChemMedChem. 2010. PMID: 20632361

5

Tyrosine kinase inhibitors influence ABCG2 expression in EGFR-positive MDCK BCRP cells via the PI3K/Akt signaling pathway.

Pick A, Wiese M. Pick A, et al. Among authors: wiese m. ChemMedChem. 2012 Apr;7(4):650-62. doi: 10.1002/cmdc.201100543. Epub 2012 Feb 22. ChemMedChem. 2012. PMID: 22354538

6

Protein contacts and ligand binding in the inward-facing model of human P-glycoprotein.

Pajeva IK, Hanl M, Wiese M. Pajeva IK, et al. Among authors: wiese m. ChemMedChem. 2013 May;8(5):748-62. doi: 10.1002/cmdc.201200491. Epub 2013 Apr 5. ChemMedChem. 2013. PMID: 23564544

7

Feature extraction via composite scoring and voting in breast cancer.

Koch M, Hanl M, Wiese M. Koch M, et al. Among authors: wiese m. Breast Cancer Res Treat. 2012 Aug;135(1):307-18. doi: 10.1007/s10549-012-2177-3. Epub 2012 Jul 26. Breast Cancer Res Treat. 2012. PMID: 22833200

8

Activators of P-glycoprotein: Structure-activity relationships and investigation of their mode of action.

Sterz K, Möllmann L, Jacobs A, Baumert D, Wiese M. Sterz K, et al. Among authors: wiese m. ChemMedChem. 2009 Nov;4(11):1897-911. doi: 10.1002/cmdc.200900283. ChemMedChem. 2009. PMID: 19777523

9

Optimization of Acryloylphenylcarboxamides as Inhibitors of ABCG2 and Comparison with Acryloylphenylcarboxylates.

Kraege S, Stefan K, Köhler SC, Wiese M. Kraege S, et al. Among authors: wiese m. ChemMedChem. 2016 Nov 21;11(22):2547-2558. doi: 10.1002/cmdc.201600455. Epub 2016 Oct 27. ChemMedChem. 2016. PMID: 27785905

10

Structure-activity relationships of flavonoids as inhibitors of breast cancer resistance protein (BCRP).

Pick A, Müller H, Mayer R, Haenisch B, Pajeva IK, Weigt M, Bönisch H, Müller CE, Wiese M. Pick A, et al. Among authors: wiese m. Bioorg Med Chem. 2011 Mar 15;19(6):2090-102. doi: 10.1016/j.bmc.2010.12.043. Epub 2010 Dec 30. Bioorg Med Chem. 2011. PMID: 21354800

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

628 results

Search Page

Filters